全文获取类型
收费全文 | 211032篇 |
免费 | 16640篇 |
国内免费 | 7247篇 |
专业分类
耳鼻咽喉 | 1261篇 |
儿科学 | 3785篇 |
妇产科学 | 2240篇 |
基础医学 | 31727篇 |
口腔科学 | 3733篇 |
临床医学 | 19872篇 |
内科学 | 34633篇 |
皮肤病学 | 2183篇 |
神经病学 | 10902篇 |
特种医学 | 4164篇 |
外国民族医学 | 32篇 |
外科学 | 16830篇 |
综合类 | 31329篇 |
现状与发展 | 17篇 |
一般理论 | 25篇 |
预防医学 | 14103篇 |
眼科学 | 5211篇 |
药学 | 25390篇 |
28篇 | |
中国医学 | 10502篇 |
肿瘤学 | 16952篇 |
出版年
2024年 | 388篇 |
2023年 | 2425篇 |
2022年 | 4930篇 |
2021年 | 6883篇 |
2020年 | 6411篇 |
2019年 | 6943篇 |
2018年 | 6765篇 |
2017年 | 6815篇 |
2016年 | 7043篇 |
2015年 | 7127篇 |
2014年 | 11624篇 |
2013年 | 13974篇 |
2012年 | 11339篇 |
2011年 | 12456篇 |
2010年 | 10466篇 |
2009年 | 10099篇 |
2008年 | 9924篇 |
2007年 | 10838篇 |
2006年 | 9857篇 |
2005年 | 9642篇 |
2004年 | 8400篇 |
2003年 | 7447篇 |
2002年 | 5617篇 |
2001年 | 5485篇 |
2000年 | 4476篇 |
1999年 | 4128篇 |
1998年 | 3062篇 |
1997年 | 2835篇 |
1996年 | 2756篇 |
1995年 | 2669篇 |
1994年 | 2337篇 |
1993年 | 2047篇 |
1992年 | 1776篇 |
1991年 | 1518篇 |
1990年 | 1245篇 |
1989年 | 1176篇 |
1988年 | 1084篇 |
1987年 | 852篇 |
1986年 | 657篇 |
1985年 | 1115篇 |
1984年 | 1277篇 |
1983年 | 905篇 |
1982年 | 979篇 |
1981年 | 857篇 |
1980年 | 776篇 |
1979年 | 655篇 |
1978年 | 537篇 |
1977年 | 430篇 |
1976年 | 503篇 |
1975年 | 422篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
Wojciech Szychta M.D. Ph.D. Gheorghe Cerin M.D. Ph.D. F.E.S.C. Bogdan Adrian Popa M.D. Armienti Felice M.D. Guido Lanzillo M.D. Ph.D. Marco Diena M.D. Grzegorz Opolski M.D. Ph.D. F.E.S.C. 《Echocardiography (Mount Kisco, N.Y.)》2015,32(6):1040-1043
Sinus venosus atrial septal defect (SV‐ASD) usually coexists with partial anomalous pulmonary vein connection (PAPVC). It is a difficult diagnosis in transthoracic echocardiography (TTE) due to eccentric position of defects. We present a rare case of atypical anatomical variation in PAPVC, which was never described before. Two right pulmonary veins drained into superior vena cava, which overrode SV‐ASD and interatrial septum, a third pulmonary vein into the right atrium. Complete diagnosis could not be set after TTE, nor transesophageal echocardiography, whereas angio‐CT was finally conclusive. This diagnostic approach allowed the surgical planning. 相似文献
22.
23.
24.
25.
26.
《Vaccine》2020,38(3):570-577
IntroductionPediatric pneumococcal pneumonia complicated by parapneumonic pleural effusion/empyema (PPE/PE) remains a major concern despite general immunization with pneumococcal conjugate vaccines (PCVs).MethodsIn a nationwide pediatric hospital surveillance study in Germany we identified 584 children <18 years of age with bacteriologically confirmed PPE/PE from October 2010 to June 2018. Streptococcus pneumoniae was identified by culture and/or PCR of blood samples and/or pleural fluid and serotyped.ResultsS. pneumoniae was identified in 256 of 584 (43.8%) children by culture (n = 122) and/or PCR (n = 207). The following pneumococcal serotypes were detected in 114 children: serotype 3 (42.1%), 1 (25.4%), 7F (12.3%), 19A (7.9%), other PCV13 serotypes (4.4%) and non-PCV13 serotypes (7.9%). Between October 2010 and June 2014 serotype 1 (38.1%) and serotype 3 (25.4%) were most prevalent, whereas between July 2014 and June 2018 serotype 3 (62.7%) and non-PCV13 serotypes (15.7%) were dominant. Compared to children with other pneumococcal serotypes, children with serotype 3 associated PPE/PE were younger (median 3.2 years [IQR 2.1–4.3 years] vs. median 5.6 years [IQR 3.8–8.2 years]; p < 0.001) and more frequently admitted to intensive care (43 [89.6%] vs. 48 [73.8%]; p = 0.04). Seventy-six of 114 (66.7%) children with pneumococcal PPE/PE had been vaccinated with pneumococcal vaccines. Thirty-nine of 76 (51.3%) had received a vaccine covering the serotype detected. Thirty of these 39 breakthrough cases were age-appropriately vaccinated with PCV13 and considered vaccine failures, including 26 children with serotype 3, three children with serotype 19A and one child with serotype 1.ConclusionFollowing the introduction of PCV13 in general childhood vaccination we observed a strong emergence of serotype 3 associated PPE/PE in the German pediatric population, including a considerable number of younger children with serotype 3 vaccine breakthrough cases and failures. Future PCVs should not only cover newly emerging serotypes, but also include a more effective component against serotype 3. 相似文献
27.
28.
《Revista espa?ola de anestesiología y reanimación》2020,67(5):245-252
Pneumonia caused by coronavirus, which originated in Wuhan, China, in late 2019, has been spread around the world already becoming a pandemic. Unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating COVID-19. Many of these patients deteriorate rapidly and require intubation and are mechanically ventilated, which is causing the collapse of the health system in many countries due to lack of ventilators and intensive care beds.In this document we review two simple adjuvant therapies to administer, without side effects, and low cost that could be useful for the treatment of acute severe coronavirus infection associated with acute respiratory syndrome (SARS-CoV-2). Vitamin C, a potent antioxidant, has emerged as a relevant therapy due to its potential benefits when administered intravenous. The potential effect of vitamin C in reducing inflammation in the lungs could play a key role in lung injury caused by coronavirus infection. Another potential effective therapy is ozone: it has been extensively studied and used for many years and its effectiveness has been demonstrated so far in multiples studies. Nevertheless, our goal is not to make an exhaustive review of these therapies but spread the beneficial effects themselves.Obviously clinical trials are necessaries, but due to the potential benefit of these two therapies we highly recommended to add to the therapeutic arsenal. 相似文献
29.
Interstitial cystitis/bladder pain syndrome (IC/BPS) and vulvodynia are chronic pain syndromes that appear to be intertwined from the perspectives of embryology, pathology and epidemiology. These associations may account for similar responses to various therapies. 相似文献
30.